Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-25-007664
Filing Date
2025-02-20
Accepted
2025-02-20 12:08:33
Documents
69
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1718366
2 ex31-1.htm EX-31.1 18980
3 ex31-2.htm EX-31.2 18635
4 ex32-1.htm EX-32.1 8343
5 ex32-2.htm EX-32.2 8166
  Complete submission text file 0001493152-25-007664.txt   9286427

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE btcy-20241231.xsd EX-101.SCH 58035
7 XBRL CALCULATION FILE btcy-20241231_cal.xml EX-101.CAL 56089
8 XBRL DEFINITION FILE btcy-20241231_def.xml EX-101.DEF 297373
9 XBRL LABEL FILE btcy-20241231_lab.xml EX-101.LAB 537759
10 XBRL PRESENTATION FILE btcy-20241231_pre.xml EX-101.PRE 413225
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 1638695
Mailing Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065
Business Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065 (650) 832-1626
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

EIN.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-40761 | Film No.: 25644115
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)